Brosseau JP - Search Results

1

Inhibiting PD-L1 palmitoylation enhances T-cell immune responses against tumours.

Yao H, Lan J, Li C, Shi H, Brosseau JP, Wang H, Lu H, Fang C, Zhang Y, Liang L, Zhou X, Wang C, Xue Y, Cui Y, Xu J. Yao H, et al. Among authors: brosseau jp. Nat Biomed Eng. 2019 Apr;3(4):306-317. doi: 10.1038/s41551-019-0375-6. Epub 2019 Mar 25. Nat Biomed Eng. 2019. PMID: 30952982

2

Author Correction: Inhibiting PD-L1 palmitoylation enhances T-cell immune responses against tumours.

Yao H, Lan J, Li C, Shi H, Brosseau JP, Wang H, Lu H, Fang C, Zhang Y, Liang L, Zhou X, Wang C, Xue Y, Cui Y, Xu J. Yao H, et al. Among authors: brosseau jp. Nat Biomed Eng. 2019 May;3(5):414. doi: 10.1038/s41551-019-0402-7. Nat Biomed Eng. 2019. PMID: 30976071

3

A peptidic inhibitor for PD-1 palmitoylation targets its expression and functions.

Yao H, Li C, He F, Song T, Brosseau JP, Wang H, Lu H, Fang C, Shi H, Lan J, Fang JY, Xu J. Yao H, et al. Among authors: brosseau jp. RSC Chem Biol. 2020 Nov 3;2(1):192-205. doi: 10.1039/d0cb00157k. eCollection 2021 Feb 1. RSC Chem Biol. 2020. PMID: 34458782 Free PMC article.

4

Targeted degradation of immune checkpoint proteins: emerging strategies for cancer immunotherapy.

Xu J, Brosseau JP, Shi H. Xu J, et al. Among authors: brosseau jp. Oncogene. 2020 Nov;39(48):7106-7113. doi: 10.1038/s41388-020-01491-w. Epub 2020 Oct 6. Oncogene. 2020. PMID: 33024277 Review.

5

NF1 heterozygosity fosters de novo tumorigenesis but impairs malignant transformation.

Brosseau JP, Liao CP, Wang Y, Ramani V, Vandergriff T, Lee M, Patel A, Ariizumi K, Le LQ. Brosseau JP, et al. Nat Commun. 2018 Nov 27;9(1):5014. doi: 10.1038/s41467-018-07452-y. Nat Commun. 2018. PMID: 30479396 Free PMC article.

6

Regulations on Messenger RNA: Wires and Nodes.

Brosseau JP. Brosseau JP. Adv Exp Med Biol. 2020;1248:251-263. doi: 10.1007/978-981-15-3266-5_11. Adv Exp Med Biol. 2020. PMID: 32185714 Review.

7

Contributions of inflammation and tumor microenvironment to neurofibroma tumorigenesis.

Liao CP, Booker RC, Brosseau JP, Chen Z, Mo J, Tchegnon E, Wang Y, Clapp DW, Le LQ. Liao CP, et al. Among authors: brosseau jp. J Clin Invest. 2018 Jul 2;128(7):2848-2861. doi: 10.1172/JCI99424. Epub 2018 May 21. J Clin Invest. 2018. PMID: 29596064 Free PMC article.

8

Spatiotemporal Loss of NF1 in Schwann Cell Lineage Leads to Different Types of Cutaneous Neurofibroma Susceptible to Modification by the Hippo Pathway.

Chen Z, Mo J, Brosseau JP, Shipman T, Wang Y, Liao CP, Cooper JM, Allaway RJ, Gosline SJC, Guinney J, Carroll TJ, Le LQ. Chen Z, et al. Among authors: brosseau jp. Cancer Discov. 2019 Jan;9(1):114-129. doi: 10.1158/2159-8290.CD-18-0151. Epub 2018 Oct 22. Cancer Discov. 2019. PMID: 30348677 Free PMC article.

9

Heterozygous Tumor Suppressor Microenvironment in Cancer Development.

Brosseau JP, Le LQ. Brosseau JP, et al. Trends Cancer. 2019 Sep;5(9):541-546. doi: 10.1016/j.trecan.2019.07.004. Epub 2019 Aug 15. Trends Cancer. 2019. PMID: 31474359 Free PMC article. Review.

10

Translating current basic research into future therapies for neurofibromatosis type 1.

Brosseau JP, Liao CP, Le LQ. Brosseau JP, et al. Br J Cancer. 2020 Jul;123(2):178-186. doi: 10.1038/s41416-020-0903-x. Epub 2020 May 22. Br J Cancer. 2020. PMID: 32439933 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

28 results

Search Page